Prostate News Archive
20-Nov-2011
Promising therapy for prostate cancer type
NEW YORK, Nov. 18 (UPI) -- A genetic Achilles' heel in an aggressive type of prostate cancer may be treated by a drug already being tested to treat other cancers, U.S. researchers say. Prostate Cancer Drug Delays Bone Cancer Spread
A new drug administered to prostate cancer patients has been shown to delay the spread of cancer to the bones, according to a new study published in the Lancet. Prostate cancer forum spotlights ?active surveillance?
ST. CATHARINES ? Gene Yaremy was diagnosed with prostate cancer in 1996 and had an operation that year. Over time, he learned the disease isn't as clear cut as you'd think.[...] Neuroendocrine Prostate Cancer - New Treatment
According to a recent report in Cancer Discovery, researchers may have discovered a new treatment for neuroendocrine prostate cancer, the most fatal subtype of prostate cancer that occurs in less than 2% of men. The more common prostate adenocarcinoma can also progress into neuroendocrine prostate cancer, which has a bleak prognosis. Mark Rubin, M.D., Professor of pathology and laboratory ...
Back to Prostate News Archive
